SAN DIEGO, Oct. 29, 2026 /PRNewswire/ — Illumina, Inc. (Nasdaq: ILMN) (“Illumina” or the “company”) today announced its financial results for the third quarter of fiscal year 2026. Third quarter 2026 results Reported revenue was $1.13 billion for Q3 2026, up 4.2% from Q3 2025. Revenue…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
